Fibrosedarstellung im Vorhof mittels MRT – ready for primetime?

Abstract

Cardiac MRI and 3 D imaging reconstruction is used clinically to assess the cardiac chambers as well as complex anatomical structures. Through the development of cardiac MRI it has become possible to detect areas of fibrosis in the left atrium that can be both, the cause and the effect of atrial fibrillation. The most recent clinical data suggests there is a strong correlation between the amount of left atrial fibrosis and recurrent atrial fibrillation following ablation. Promising future developments will allow individualized therapy for patients with atrial fibrillation in addition to improving safety and procedure results after ablation. The technological advances and the increasing availability of MRI sequences and the necessary software make the detection of left atrial fibrosis using the MRI actually ready for prime time.

• Literatur

• 1 Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375
• 2 Haissaguerre M et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666
• 3 Schotten U, Verheule S, Kirchhof P et al. Patho-physiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 2011; 91: 265-325
• 4 Wijffels MC, Kirchhof CJ, Dorland R et al. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995; 92: 1954-1968
• 5 Kim RJ, Fieno DS, Parrish TB et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002
• 6 Karim R, Housden RJ, Balasubramaniam M et al. Evaluation of current algorithms for segmentation of scar tissue from late gadolinium enhancement cardiovascular magnetic resonance of the left atrium: an open-access grand challenge. J Cardiovasc Magn Reson 2013; 15: 105
• 7 Mahnkopf C, Badger TJ, Burgon NS et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm 2010; 7: 1475-1481 Epub 2010 Jul 1
• 8 Akoum N, Daccarett M, McGann C et al. Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol 2011; 22: 16-22
• 9 Daccarett M, Badger TJ, Akoum N et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol 2011; 57: 831-838
• 10 Gladstone D, Bui E, Fang J et al. Potentially Preventable Strokes in High-Risk Patients with Atrial Fibrillation are not adequately anticoagulated. Stroke 2009; 40: 235-240
• 11 Marrouche N, Wilber D, Hindricks G et al. Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation, The DECAAF Study. JAMA 2014; 311: 498-506